You are here

funding

Verdiva Bio raises $411m for obesity pipeline

Pharmaphorum

Thu, 01/9/25 - 11:06 am

Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases

PR Newswire

Wed, 01/8/25 - 11:33 am

Alesta Therapeutics

small molecule drugs

XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease

BioSpace

Tue, 01/7/25 - 11:33 am

cardiovascular disease

Orbis raises $93M to turn popular biologics into pills

BioPharma Dive

Mon, 01/6/25 - 10:50 am

Orbis Medicines

Neuralink rival Precision raises $102m, and other financings

Pharmaphorum

Fri, 12/20/24 - 11:09 am

Precision Neurosciences

brain-computer interfaces

Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic

Fierce Biotech

Thu, 12/19/24 - 11:29 am

Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs

BioSpace

Thu, 12/19/24 - 11:27 am

Gilead Sciences

Atlas doubles down on ‘disciplined’ biotech investing with latest fundraise

BioPharma Dive

Thu, 12/5/24 - 04:11 pm

Nuvig pulls in $161M to make better immune drugs

BioPharma Dive

Thu, 12/5/24 - 11:11 am

Maze Therapeutics Raises $115M in Series D Financing

FinSMEs

Tue, 12/3/24 - 11:31 am

Maze Therapeutics

Novo Holdings-backed Adcendo secures $135M for ADC pipeline

Fierce Biotech

Mon, 11/25/24 - 11:10 am

antibody-drug conjugate

Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1

BioSpace

Wed, 11/13/24 - 11:20 am

TRex Bio raises $84M to compete in crowded immune drug field

BioPharma Dive

Wed, 11/13/24 - 10:51 am

Disc Medicine secures $200m financing to support trials

Clinical Trials Arena

Mon, 11/11/24 - 11:30 am

clinical trials

Neurogene secures $200M ahead of anticipated study readout

BioPharma Dive

Mon, 11/4/24 - 06:55 pm

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies

PR Newswire

Wed, 10/30/24 - 11:52 am

Blue Earth Therapeutics

A new biotech, built around protein design, springs from David Baker’s lab

BioPharma Dive

Wed, 10/30/24 - 11:45 am

Archon Biosciences

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Pharmaceutical Technology

Fri, 10/25/24 - 11:08 am

fibrotic disease

As new Alzheimer’s biomarkers come into play, here’s where the money is going

Pharma Voice

Thu, 10/17/24 - 09:20 am

Alzheimer's disease

KdT Ventures Announces Oversubscribed Fund IV to Invest in Early-Stage Frontier Science Companies

Businesswire

Wed, 10/16/24 - 05:24 pm

Pages